| Price | 11.17 |
| Price Change Today | -$0.39 (-3.37%) |
| P&P rating | ![]() |
| Zacks Rank | 3 - HOLD |
| Open Price | $11.62 |
| Previous Close | $11.56 |
| Daily Range | $10.92 - $11.70 |
| 52-Week Range | $2.67 - $15.25 |
| Volume | 2,206,710 |
| Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus. | |





Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment